Abiopharma

News list

REINEMUND STEVEN 🟢 acquired 16.1K shares of McGraw Hill, Inc. (MH) Transaction Date: Aug 11, 2026 | Filing ID: 349226

Full text

News bot Aug. 13, 2026, 8:16 p.m.
🔍 REINEMUND STEVEN (Executive)

Company: McGraw Hill, Inc. (MH)

Report Date: 2026-08-11
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 16,086
- Total shares held: 73,710
Detailed Transactions and Holdings:
- Acquired 16,086 shares of Common Stock (Direct)
  Date: 2026-08-11 | Code: A | equity_swap_involved: false | shares_owned_after: 26,968.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-11 | Code: H | nature_of_ownership: By The Gail T Reinemund Irrevocable Trust FBO | shares_owned_after: 73,710.00 | Footnotes: F2
Footnotes:
- F1: On 8/11/2026, the Reporting Person received a grant of 16,086 restricted stock units ("RSUs") that vest on the earlier of (i) the date of Issuer's 2027 annual meeting of stockholders or (ii) August 11, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through each such date. Each RSU represents the right to receive one (1) share of Common Stock upon vesting of the unit.
- F2: The reporting person indirectly beneficially owns these securities through The Gail T Reinemund Irrevocable Trust FBO. The reporting person is trustee of the trust, and members of his immediate family are the sole beneficiaries of the trust.